Implementation of Data Generated from Competitive Analysis into Investor Presentation
With increased scrutiny of early stage investment for biotech start-ups linked to economics downturn from its peak in 2020-2021, targeted investor engagement is key for a successful financing round. Despite possessing highly derisked and innovative technology, data presentation must be refined in a highly digestable manner to attract interest from notable investors and potential strategic partners. Thus, we propose that the implementation of our data generated based on competitive analysis in our investor presentation will strengthen our engagement with investors. Through the identification of early stage investor pipeline for engagement and refining data targeted towards the audience’s level of technical understanding, we believe that the successful completion of this project will help us secure financing towards HDAX Therapeutics’ seed round.
View Full Project DescriptionPatrick Gunning
HDAX Therapeutics
Life Sciences
Professional, scientific and technical services
University of Toronto
Business Strategy Internship